A multitalented team
developing a breakthrough product
to achieve widespread access and measurable impact


We have been able to prevent viral infection of cells with our product. We are currently validating its efficacy in animal models, and gaining a deeper understanding of its chemistry and its biology


Jesús Purroy, PhD · Entrepreneur
Doctor in Biology (University of Barcelona) and IESE PDD. He worked as a biomedical researcher in academia and industry in Europe and the USA. In 2007 he joined the Barcelona Science Park, where he acted on several managing positions. In 2012 he co-founded a pharmaceutical company, and later he co-founded a consulting company.


Àvida Biotech was funded by its founders and by angel investors in 4Q2016. In 2Q2017 we will seek another financing round to complete the preclinical development of our lead product.
Our business model is based on selling affordable products to people at the bottom of the pyramid. Because of this, we are particularly interested in working with impact investors. Let us know if you would like to know more about our plans.